BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 11, 2026
Home » Authors » John Fox

John Fox

Articles

ARTICLES

New blood test developed for early Alzheimer's diagnosis

April 22, 2019
By John Fox
South Korean neuroscientists and bioengineers have successfully developed a new blood test for Alzheimer's disease (AD), which was shown to be capable of rapidly distinguishing between AD patients and individuals with normal cognition, with selectivity and sensitivity exceeding 90%.
Read More

New blood test developed for early Alzheimer's diagnosis

April 19, 2019
By John Fox

Researchers unveil first anisotropic knee meniscus engineered from stem cells

April 18, 2019
By John Fox

Researchers unveil first anisotropic knee meniscus engineered from stem cells

April 18, 2019
By John Fox
A tissue-engineered knee meniscus, seeded with mesenchymal stem cells (MSCs) under biomechanical and biochemical stimuli in vitro, has been shown to promote anisotropy and have a functional chondroprotective effect on the knee, a Chinese study reported in the April 10, 2019, issue of Science Translational Medicine.
Read More

Glioblastoma-on-a-chip predicts therapeutic responses

April 3, 2019
By John Fox
Korean bioengineers and neurosurgeons have developed a novel patient-specific bioprinted tumor-on-a-chip model of glioblastoma, which might prove useful for identifying optimal treatments for patients resistant to standard first-line therapies.
Read More

Glioblastoma-on-a-chip used to predict therapeutic response

April 1, 2019
By John Fox

Glioblastoma-on-a-chip predicts therapeutic responses

April 1, 2019
By John Fox
Korean bioengineers and neurosurgeons have developed a novel patient-specific bioprinted tumor-on-a-chip model of glioblastoma, which might prove useful for identifying optimal treatments for patients resistant to standard first-line therapies.
Read More

Eye patches now for drug delivery, not just pirates

Nov. 14, 2018
By John Fox
A miniature eye patch delivering drugs directly into the eye for safer and more effective treatment of ocular diseases has been reported by researchers at Singapore's Nanyang Technological University in the Nov. 6, 2018, edition of Nature Communications.
Read More

Eye patches now for drug delivery, not just pirates

Nov. 9, 2018
By John Fox

Eye patches now for drug delivery, not just pirates

Nov. 7, 2018
By John Fox
A miniature eye patch delivering drugs directly into the eye for safer and more effective treatment of ocular diseases has been reported by researchers at Singapore's Nanyang Technological University in the Nov. 6, 2018, edition of Nature Communications.
Read More
View All Articles by John Fox

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 11, 2026.
  • Rendering of a key measles protein targeted by neutralizing human antibodies

    First measles treatment advances as vaccination rates drop

    BioWorld
    Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
  • Infensa Bioscience identifies new ASIC blockers

    BioWorld Science
    Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
  • Close up of bow of cruise ship

    Hantavirus is ‘sentinel’ more than acute pandemic threat

    BioWorld
    News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
  • Neurology illustration

    Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst

    BioWorld
    Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing